Sirenas LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Sirenas LLC (Sirenas), formerly Sirenas Marine Discovery LLC, is a biotechnology company that discovers therapeutics derived from natures chemistry. The companys proprietary data mining technologyATLANTIS uses data mining and machine learningapproach to uncover the therapeutic potential of natures chemistry. Its pipeline products are used for sting pathway antagonist, t-cell activation, infectious disease and innate immunity. The company uses its pipeline products for immuno-oncology and infectious disease programs.It partners with pharmaceutical companies and research foundations to widen the use of its ATLANTI technology. Sirenas is headquartered in San Diego, California, the US.

Sirenas LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sirenas LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sirenas LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sirenas LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Sirenas Marine Raises Us$1.3 Million In Venture Financing 10
Partnerships 11
Sirenas Enters into Research Agreement wiith Bristol-Myers Squibb 11
Sirenas to Enter into Agreement with California Institute for Biomedical Research 12
Sirenas LLC - Key Competitors 13
Sirenas LLC - Key Employees 14
Sirenas LLC - Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
Dec 13, 2017: Sirenas Receives Research Grant Totaling $1.68 M To Accelerate Its Drug Discovery Technology, ATLANTIS 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List Of Tables


Sirenas LLC, Pharmaceuticals & Healthcare, Key Facts 2
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sirenas LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sirenas LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Sirenas LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sirenas Marine Raises Us$1.3 Million In Venture Financing 10
Sirenas Enters into Research Agreement wiith Bristol-Myers Squibb 11
Sirenas to Enter into Agreement with California Institute for Biomedical Research 12
Sirenas LLC, Key Competitors 13
Sirenas LLC, Key Employees 14

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Sirenas LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sirenas LLC (Sirenas), formerly Sirenas Marine Discovery LLC, is a biotechnology company that discovers therapeutics derived from natures chemistry. The companys proprietary data mining technologyATLANTIS uses data mining and machine

USD 250 View Report

IXYS LLC - Strategic SWOT Analysis Review

IXYS LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on

USD 125 View Report

Prometheon Pharma LLC - Product Pipeline Analysis, 2019 Update

Prometheon Pharma LLC - Product Pipeline Analysis, 2019 Update market research report available in single user pdf license with Aarkstore Enterprise at USD 750

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available